Market Cap 30.19B
Revenue (ttm) 15.46B
Net Income (ttm) 1.03B
EPS (ttm) N/A
PE Ratio 14.81
Forward PE 15.94
Profit Margin 6.66%
Debt to Equity Ratio 0.66
Volume 22,120,100
Avg Vol 28,617,186
Day's Range N/A - N/A
Shares Out 1.92B
Stochastic %K 13%
Beta 0.72
Analysts Sell
Price Target $21.50

Company Profile

Kenvue Inc. operates as a consumer health company in the United States, Europe, the Middle East, Africa, Asia-Pacific, and Latin America. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands. Its Skin Health and Beauty segment...

Industry: Household & Personal Products
Sector: Consumer Defensive
Address:
1 Kenvue Way, Summit, United States
StockAutoPro
StockAutoPro Oct. 4 at 9:34 PM
$KVUE: Buy target $13.81 Sell target $16.6 E-commerce growth could boost key players in the KVUE sector. Consider long-term investments.
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Oct. 4 at 8:34 PM
$JNJ $KVUE millions??? You’re talking about millions??? It’s a $100 BILLION company!!! … You realize all of these cases are now being litigated separately. Pretty clear you are clueless about the legal system, but there’s no fast lane. Try to litigate thousands of claims individually against a defendant with endless resources. Firms don’t have the resource or the time for that and are dropping and selling the claims… if you’re so confident yolo on puts and post the proof. Otherwise sit down and shut up. Impressive entry level Benz you were able to lease with all our success in the market over the last 30 years. 😂😂😂
0 · Reply
Suite510
Suite510 Oct. 4 at 1:01 PM
$JNJ $KVUE lol a meatball twit 🤓👋💵 Judge Adds $10M Punitive Award: J&J Was 'Indifferent, 'Willfully Ignorant' About Talc's Health Risks On Wednesday, a Connecticut judge added $10 million in punitive damages against Johnson & Johnson after a jury's $15 million verdict last year to a man who alleged its baby powder caused his mesothelioma.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 8:46 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $KVUE Current Share Price: $15.81 Contracts: $KVUE January 15, 2027 $18 Calls Scale in: $2.12- $2.59 Scale out: $3.29-$4.23 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 4 at 6:24 AM
$KVUE - Kenvue is so oversold, but oversold can stay oversold for a long time. But, I see a bounce to $18-19 by end of the year, if not sooner. $SPY
0 · Reply
spacechimp
spacechimp Oct. 4 at 1:50 AM
$KVUE 😂 🤷‍♂️
1 · Reply
Californiamaster
Californiamaster Oct. 4 at 12:42 AM
$KVUE due for bounce. Enough of fake news by government
0 · Reply
oftenlongphong
oftenlongphong Oct. 3 at 9:12 PM
$KVUE I sold last year, but adding slowly as we go along. Figured downside risk is low since there's no history of mommy headaches that a few sprinkles of talcum powder or Tylenol can't make better.
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 3 at 8:36 PM
$KVUE - Was this a fluke on ST? 😂
1 · Reply
Newcar
Newcar Oct. 3 at 8:04 PM
$KVUE GREEN 👍
0 · Reply
Latest News on KVUE
51 September S&P Hi-Yield Aristocrats: 5 To Buy

Sep 26, 2025, 7:08 AM EDT - 8 days ago

51 September S&P Hi-Yield Aristocrats: 5 To Buy

AMCR AVA BEN EIX FLO HRL KO


Kenvue: This Too Shall Pass

Sep 24, 2025, 2:36 PM EDT - 10 days ago

Kenvue: This Too Shall Pass


Kenvue Stock Recoups Losses After Trump Links Tylenol to Autism

Sep 23, 2025, 3:20 PM EDT - 11 days ago

Kenvue Stock Recoups Losses After Trump Links Tylenol to Autism


Tylenol: Kenvue's Sobering Reality

Sep 23, 2025, 10:43 AM EDT - 11 days ago

Tylenol: Kenvue's Sobering Reality


Trump Sounds The Alarm On Tylenol

Sep 23, 2025, 7:30 AM EDT - 11 days ago

Trump Sounds The Alarm On Tylenol


Wall Street Breakfast Podcast: Kenvue In Focus

Sep 23, 2025, 6:33 AM EDT - 11 days ago

Wall Street Breakfast Podcast: Kenvue In Focus

BA META


Tylenol-maker Kenvue shares bounce, Trump claims face pushback

Sep 23, 2025, 4:01 AM EDT - 11 days ago

Tylenol-maker Kenvue shares bounce, Trump claims face pushback


Final Trade: AAPL, C, PFE, KVUE

Sep 22, 2025, 6:34 PM EDT - 11 days ago

Final Trade: AAPL, C, PFE, KVUE

AAPL C PFE


Top Stock Movers Now: Nvidia, Apple, Kenvue, and More

Sep 22, 2025, 2:20 PM EDT - 12 days ago

Top Stock Movers Now: Nvidia, Apple, Kenvue, and More

AAPL NVDA


StockAutoPro
StockAutoPro Oct. 4 at 9:34 PM
$KVUE: Buy target $13.81 Sell target $16.6 E-commerce growth could boost key players in the KVUE sector. Consider long-term investments.
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Oct. 4 at 8:34 PM
$JNJ $KVUE millions??? You’re talking about millions??? It’s a $100 BILLION company!!! … You realize all of these cases are now being litigated separately. Pretty clear you are clueless about the legal system, but there’s no fast lane. Try to litigate thousands of claims individually against a defendant with endless resources. Firms don’t have the resource or the time for that and are dropping and selling the claims… if you’re so confident yolo on puts and post the proof. Otherwise sit down and shut up. Impressive entry level Benz you were able to lease with all our success in the market over the last 30 years. 😂😂😂
0 · Reply
Suite510
Suite510 Oct. 4 at 1:01 PM
$JNJ $KVUE lol a meatball twit 🤓👋💵 Judge Adds $10M Punitive Award: J&J Was 'Indifferent, 'Willfully Ignorant' About Talc's Health Risks On Wednesday, a Connecticut judge added $10 million in punitive damages against Johnson & Johnson after a jury's $15 million verdict last year to a man who alleged its baby powder caused his mesothelioma.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 8:46 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $KVUE Current Share Price: $15.81 Contracts: $KVUE January 15, 2027 $18 Calls Scale in: $2.12- $2.59 Scale out: $3.29-$4.23 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 4 at 6:24 AM
$KVUE - Kenvue is so oversold, but oversold can stay oversold for a long time. But, I see a bounce to $18-19 by end of the year, if not sooner. $SPY
0 · Reply
spacechimp
spacechimp Oct. 4 at 1:50 AM
$KVUE 😂 🤷‍♂️
1 · Reply
Californiamaster
Californiamaster Oct. 4 at 12:42 AM
$KVUE due for bounce. Enough of fake news by government
0 · Reply
oftenlongphong
oftenlongphong Oct. 3 at 9:12 PM
$KVUE I sold last year, but adding slowly as we go along. Figured downside risk is low since there's no history of mommy headaches that a few sprinkles of talcum powder or Tylenol can't make better.
0 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 3 at 8:36 PM
$KVUE - Was this a fluke on ST? 😂
1 · Reply
Newcar
Newcar Oct. 3 at 8:04 PM
$KVUE GREEN 👍
0 · Reply
Napo1eon
Napo1eon Oct. 3 at 7:51 PM
$KVUE Market is up 270 and we can't hold 10 cents
0 · Reply
Wuptich
Wuptich Oct. 3 at 7:36 PM
$KVUE 10-15% Move in Ah 🚨🚨🚨🚨🚀🚀🚀🚀😂
0 · Reply
nvda_wins_at_the_end
nvda_wins_at_the_end Oct. 3 at 7:06 PM
$KVUE bought back all sold call. By end of the day all will be gone and moving to another one.
0 · Reply
nvda_wins_at_the_end
nvda_wins_at_the_end Oct. 3 at 7:06 PM
$KVUE 2k shares and $300 down.
0 · Reply
Deeznutsswapmeet
Deeznutsswapmeet Oct. 3 at 6:47 PM
$JNJ $KVUE Have you ever been right about anything?
2 · Reply
Newcar
Newcar Oct. 3 at 6:12 PM
$KVUE could this be the first green day after so much red?
1 · Reply
Napo1eon
Napo1eon Oct. 3 at 6:06 PM
$KVUE One step forward and two steps back!
0 · Reply
RunnerSignals
RunnerSignals Oct. 3 at 5:19 PM
$KVUE $KDP showing extreme RSI readings while $BSX $DOCU setting up for potential bounces. Volume dried up = seller exhaustion? https://stocksrunner.com/news/2025-10-03-top-oversold-stocks-with-strong-technical-reversal-signals
0 · Reply
Napo1eon
Napo1eon Oct. 3 at 5:10 PM
$KVUE Trump did a number on this stock.
1 · Reply
ModelsandBottles
ModelsandBottles Oct. 3 at 4:59 PM
$KVUE ouch
0 · Reply
Abovezero0000
Abovezero0000 Oct. 3 at 4:44 PM
$KVUE Since the ”lawsuits” are gonna reference this 2024 study as new evidence in an attempt to link Tylenol to autism, it should be very easy for Kenvue to defend these such suits now that they have evidence showing the co-authors of that study indicating and referencing that “acetaminophen use during pregnancy does not cause autism.”
1 · Reply
JoeCoolTrader
JoeCoolTrader Oct. 3 at 4:40 PM
$KVUE - Based on November options, looks like Kenvue price could be pulled up north of $18. $SPY
0 · Reply